Patent Assignment
Reel/Frame 029105/0808
Assignment of Assignor's Interest
Recorded: 2012-10-10
Pages: 12
Assignor
ARYX THERAPEUTICS, INC.
Executed: 2012-08-15
Assignee
ARMETHEON, INC.
325 SHARON PARK DRIVE, # 303, MENLO PARK, CALIFORNIA, 94025
Covered Properties
(6)
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent:
6,372,783 →
Application:
09/680,873 →
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent:
6,362,223 →
Application:
09/684,046 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Correction of Assignors, Peter G. Milner Was Accidently Omitted, When Assignment Previously Recorded at Reel/Frame 029105/0808
Oct 26, 2012
From: DRUZGALA, PASCAL; MILNER, PETER G.
To: ARYX THERAPEUTICS
Reel/Frame 029201/0099 →
Release of Security Interest
Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Security Interest
Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name
Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest
Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →